Austrian Patent Office Issues Favorable Ruling for Ranbaxy

Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories (Ranbaxy), announced that it successfully invalidated claims 1-3 (all claims sought to be invalidated) of Austrian Patent No. AT E 207 896 as anticipated by, and as lacking inventive step over, respectively, a Pfizer-owned published patent application and a Pfizer owned patent, as reflected by a decision released by the Austrian Patent Office.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/03-29-2005/0003288569&EDATE=)